From owner-cypherpunks@Algebra.COM  Sun Oct 14 20:01:03 2001
Return-Path: <owner-cypherpunks@Algebra.COM>
Received: from fort-point-station.mit.edu (FORT-POINT-STATION.MIT.EDU [18.72.0.53])
	by positron.mit.edu (8.11.6/8.9.3) with ESMTP id f9F00x509532
	for <kwantam@positron.mit.edu>; Sun, 14 Oct 2001 20:01:03 -0400
Received: from ak47.algebra.com (ak47.algebra.com [208.233.99.160])
	by fort-point-station.mit.edu (8.9.2/8.9.2) with ESMTP id UAA21535
	for <rsw@mit.edu>; Sun, 14 Oct 2001 20:00:50 -0400 (EDT)
Received: (from majordom@localhost)
	by ak47.algebra.com (8.11.1/8.11.1) id f9ENuRw07440
	for cypherpunks-outgoing; Sun, 14 Oct 2001 18:56:27 -0500
X-Authentication-Warning: ak47.algebra.com: majordom set sender to owner-cypherpunks@Algebra.COM using -f
Received: from slack.lne.com (dns.lne.com [209.157.136.81])
	by ak47.algebra.com (8.11.1/8.11.1) with ESMTP id f9ENuKS07423
	for <cypherpunks@algebra.com>; Sun, 14 Oct 2001 18:56:20 -0500
Received: (from cpunk@localhost)
	by slack.lne.com (8.11.0/8.11.0) id f9ENuGg11295
	for cypherpunks@algebra.com; Sun, 14 Oct 2001 16:56:16 -0700
Received: (from majordom@localhost)
	by slack.lne.com (8.11.0/8.11.0) id f9ENtrV11286
	for cypherpunks-goingout; Sun, 14 Oct 2001 16:55:53 -0700
X-Authentication-Warning: slack.lne.com: majordom set sender to owner-cypherpunks@lne.com using -f
Date: Sun, 14 Oct 2001 16:55:45 -0700
From: "Karsten M. Self" <kmself@ix.netcom.com>
To: Cypherpunks List <cypherpunks@lne.com>
Old-Subject: Re: [OT] Anthrax protocol issued.
Message-ID: <20011014165545.D7020@navel.introspect>
Mail-Followup-To: Cypherpunks List <cypherpunks@lne.com>
References: <Pine.BSF.4.21.0110141246310.18927-100000@greeves.mfn.org>
Mime-Version: 1.0
Content-Type: text/plain; charset="us-ascii"
Content-Disposition: inline
User-Agent: Mutt/1.3.17i
In-Reply-To: <Pine.BSF.4.21.0110141246310.18927-100000@greeves.mfn.org>;
  from measl@mfn.org on Sun, Oct 14, 2001 at 12:48:21PM -0500
X-Debian-GNU-Linux: Rocks
X-Kuro5hin-cabal: There is no K5 cabal
X-GPG-Fingerprint: F932 8B25 5FDD 2528 D595  DC61 3847 889F 55F2 B9B0
X-uptime: 00:48:06 up 19 days,  2:30, 16 users,  load average: 3.79,
  4.36, 4.13
X-Converted-To-Plain-Text: from multipart/signed by demime 0.97c
X-Converted-To-Plain-Text: Alternative section used was text/plain
X-Loop: cypherpunks@lne.com
X-spam: 10 
Subject:  Re: [OT] Anthrax protocol issued.
X-Algebra: <A HREF=http://www.algebra.com>Algebra</A>
Sender: owner-cypherpunks@Algebra.COM
Precedence: bulk
X-Mailing-List: cypherpunks@algebra.com
X-List-Admin: ichudov@algebra.com
X-Loop: cypherpunks@algebra.com
X-spam: 10 
Status: O
Content-Length: 6827
Lines: 159


Cleaned up.

on Sun, Oct 14, 2001 at 12:48:21PM -0500, measl@mfn.org (measl@mfn.org)
wrote:
> Interesting even though OT.
>
> --
> Yours,
> J.A. Terranson
> sysadmin@mfn.org
>
> ---------------------------------
> Guidelines for Responding to "Anthrax Threats"
>
>
> "Anthrax Threats" (Letters, Packages, etc.)
>
>     - Notify local law enforcement and the Federal Bureau of
>       Investigation (FBI) [Atlanta Field Office, 404-679-9000, 24/7].
>
>     - Double bag the letter or package in plastic bags using latex
>       gloves and a particulate (or TB) mask.
>
>     - Ensure that all persons who have touched the letter (package) wash
>       their hands with soap and water.
>
>     - Ensure that all persons who have touched the letter (package)
>       remain on site until emergency personnel arrive; list all persons
>       who physically handled the letter (package) and provide the list
>       to authorities.
>
>     - Notify local, district, and state public health (see contact
>       numbers at the end of this document).
>
>     - Substances in letters can be tested at the Georgia Public Health
>       Laboratory (GPHL) at the request of the FBI.
>
>     - Decisions about the need for decontamination and initiation of
>       antibiotic prophylaxis should be made in consultation with public
>       health officials.  In most circumstances, the decision to initiate
>       prophylaxis can be delayed until the presence or absence of
>       Bacillus anthracis can be determined.
>
>     - CDC currently does NOT recommend the use of nasal swab specimens
>       as part of evaluating anthrax threats/implied threats or
>       evaluating concerned citizens who think they may have been exposed
>       to anthrax.
>
>     - For further information see:
>       http://www.cdc.gov/mmwr/preview/mmwrhtml/00056353.htm
>
>
>
> Asymptomatic Persons WITHOUT Known Exposure to Anthrax
> ("Worried well" -- includes low risk threats)
>
>     - Provide reassurance about the low risk for infection without known
>       exposure and education about anthrax as an agent in bioterrorism;
>
>     - Recommend referral to private health care provider for further
>       concerns and/or diagnostics as deemed appropriate.  Currently, no
>       screening tests are available for the detection of anthrax
>       infection in the absence of symptoms.  Nasal swabs may be useful
>       as an epidemiologic tool when a confirmed case is identified but
>       are not routinely used for diagnosis or screening. CDC currently
>       does NOT recommend the use of nasal swab specimens as part of
>       evaluating anthrax threats/implied threats or evaluating concerned
>       citizens who think they may have been exposed to anthrax.
>
>
>
> Asymptomatic Persons WITH Known Exposure to Anthrax or to Credible
> Anthrax Threats
>
>     - Conduct individual risk assessment in coordination with public
>       health officials and refer to private health care provider if
>       post-exposure prophylaxis is necessary.  Currently, no screening
>       tests are available for the detection of anthrax infection in the
>       absence of symptoms.  Although data are limited, nasal swabs may
>       be useful if performed early (within 0-24 hours) following known
>       or credible inhalation exposure to B. anthracis.
>
>     - In this situation, decontamination of patients and their clothing
>       is NOT routinely recommended.
>
>     - Patients should be educated regarding clinical symptoms of anthrax
>       infection and advised to seek medical attention immediately if
>       they develop fever or flu-like illness.
>
>     - Postexposure Prophylaxis (PEP) Recommendations : (Inglesby, et al.
>       Anthrax as a Biological Weapon: Medical and Public Health
>       Management, JAMA 1999; 281 (No. 18): 1735-45.)
>
>     - Adults: Initially ciprofloxacin 500 mg orally q 12 hrs. Optimal
>       PEP for adults (once susceptibility is known) amoxicillin 500 mg
>       orally q 8 hrs or doxycycline 100 mg orally q 12 hrs.
>
>     - Children: Initially ciprofloxacin 20-30 mg/kg per day orally
>       divided into 2 daily doses, not to exceed 1 g/d.  Optimal PEP for
>       children (once susceptibility is known) if child <20 kg,
>       administer amoxicillin 40 mg/kg divided into 3 doses q 8 hrs; if
>       child > or = 20 kg give amoxicillin 500 mg orally q 8 hrs.
>
>     - Postexposure prophylaxis should be continued for 60 days.
>
>     - Postexposure prophylaxis may be discontinued if laboratory studies
>       and investigation have ruled out the presence of B. anthracis.
>
>
>
> Hospitalized Patients with Symptoms Compatible with Anthrax
>
>     - Immediately notify local, district, and state public health
>       officials so that rapid epidemiologic investigation can be
>       initiated.
>
>     - Confirm the diagnosis: Obtain the appropriate laboratory specimens
>       based on clinical form of anthrax (inhalational, gastrointestinal,
>       or cutaneous) suspected.
>
>     - Specimens for possible cutaneous anthrax: vesicular fluid (Gram
>       stain & culture) and/or blood cultures
>
>     - Specimens for possible gastrointestinal anthrax: vomitus, feces,
>       and/or blood cultures
>
>     - Specimens for possible inhalational anthrax: nasal swab, blood,
>       CSF, and/or sputum cultures
>
>     - For further information on specimen collection and handling, refer
>       to protocol "Laboratory Procedures for the identification of
>       Bacillus anthracis".
>
>     - Note: A widened mediastinum on chest radiograph with respiratory
>       distress in a previously healthy patient with antecedent flu-like
>       illness is highly suspect for advanced inhalational anthrax.
>
>     - Initial microbiologic testing for presumptive anthrax diagnosis
>       should be performed in hospital clinical laboratories according to
>       the protocol "Laboratory Procedures for the identification of
>       Bacillus anthracis"..
>
>     - The Georgia Public Health Laboratory serves as a reference
>       laboratory and can confirm suspect bacterial isolates but are not
>       equipped to routinely culture primary clinical specimens (blood,
>       sputum, etc.) except in emergency situations or if the hospital
>       clinical laboratory is unable to perform the presumptive tests.
>
>

--
Karsten M. Self <kmself@ix.netcom.com>       http://kmself.home.netcom.com/
 What part of "Gestalt" don't you understand?             Home of the brave
  http://gestalt-system.sourceforge.net/                   Land of the free
   Free Dmitry! Boycott Adobe! Repeal the DMCA! http://www.freesklyarov.org
Geek for Hire                     http://kmself.home.netcom.com/resume.html

[demime 0.97c removed an attachment of type application/pgp-signature]

